Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2016-05, Vol.24 (5), p.1935-1937
Main Authors: Lehmacher, W., Klasser, M., Duering, A.
Format: Article
Language:English
Subjects:
Cancer patients
Febrile Neutropenia - prevention & control
Female
Filgrastim - therapeutic use
Granulocyte Colony-Stimulating Factor - therapeutic use
Health aspects
Humans
Letter to the Editor
Lymphoma, Non-Hodgkin - drug therapy
Medicine
Medicine & Public Health
Neutropenia
Nursing
Nursing Research
Oncology
Pain Medicine
Primary Prevention
Rehabilitation Medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833
cites cdi_FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833
container_end_page 1937
container_issue 5
container_start_page 1935
container_title Supportive care in cancer
container_volume 24
creator Lehmacher, W.
Klasser, M.
Duering, A.
description
doi_str_mv 10.1007/s00520-016-3116-3
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4805708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A447313570</galeid><sourcerecordid>A447313570</sourcerecordid><originalsourceid>FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833</originalsourceid><addsrcrecordid>eNp1Ustu1DAUjRCIDoUPYIMssekmxY6dOGGBVI1oQRqJBbC2HOcm45LYg-2ZaljxEfwUv8GXcMOU0iKQJdvyPefch0-WPWX0lFEqX0RKy4LmlFU5Z_N2L1swwXkuOW_uZwvaCJYLXpZH2aMYLyllUpbFw-yoqOqK1kIusu8rSAkCSZ6kNRDobPLhJXGeWGcC6Agd6aENdgTiYJuC34CzmgQbP80ko51B-kYnCy5FEsCA3Vk3kNFuYOjtOAQdk51-fP1mfMBwst4R3xNN4j4mmJBpkLazcEW068gESefa6XEfbZyBAV_9ZL9gJcY7rGAc8ZqC1WMkVzatyUW-fH_-OHvQ4ws8uT6Ps4_nrz8s3-Srdxdvl2er3JRcppw3Rsu6YUUhexCtgIZzwWpZtlWvNe-BtkVXMdaC7BrBWyZ0X-rCtGCqmtWcH2evDrqbbTtBZ7DtoEe1CXbSYa-8tupuxNm1GvxOiZqWktYocHItEPznLcSkJhsNjKN24LdR4SdVFAssK4Q-_wt66bcBZ_MLVXKKdYs_qEGPoKzrPeY1s6g6E0JyxjEvok7_gcLVwWRxsIB_BXcJ7EAwwccYoL_pkVE1-08d_KfQf2r2n5qH8-z2cG4Yvw2HgOIAiBhyA4RbHf1X9SdiR-sZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1775308754</pqid></control><display><type>article</type><title>Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF</title><source>Social Science Premium Collection</source><source>Sociology Collection</source><source>Springer Link</source><creator>Lehmacher, W. ; Klasser, M. ; Duering, A.</creator><creatorcontrib>Lehmacher, W. ; Klasser, M. ; Duering, A.</creatorcontrib><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-016-3116-3</identifier><identifier>PMID: 26860847</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer patients ; Febrile Neutropenia - prevention &amp; control ; Female ; Filgrastim - therapeutic use ; Granulocyte Colony-Stimulating Factor - therapeutic use ; Health aspects ; Humans ; Letter to the Editor ; Lymphoma, Non-Hodgkin - drug therapy ; Medicine ; Medicine &amp; Public Health ; Neutropenia ; Nursing ; Nursing Research ; Oncology ; Pain Medicine ; Primary Prevention ; Rehabilitation Medicine</subject><ispartof>Supportive care in cancer, 2016-05, Vol.24 (5), p.1935-1937</ispartof><rights>The Author(s) 2016</rights><rights>COPYRIGHT 2016 Springer</rights><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833</citedby><cites>FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1775308754/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1775308754?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,786,790,891,21422,21423,27957,27958,33646,33647,34565,34566,43768,44150,74578,74996</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26860847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lehmacher, W.</creatorcontrib><creatorcontrib>Klasser, M.</creatorcontrib><creatorcontrib>Duering, A.</creatorcontrib><title>Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><subject>Cancer patients</subject><subject>Febrile Neutropenia - prevention &amp; control</subject><subject>Female</subject><subject>Filgrastim - therapeutic use</subject><subject>Granulocyte Colony-Stimulating Factor - therapeutic use</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Lymphoma, Non-Hodgkin - drug therapy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neutropenia</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Pain Medicine</subject><subject>Primary Prevention</subject><subject>Rehabilitation Medicine</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2R</sourceid><recordid>eNp1Ustu1DAUjRCIDoUPYIMssekmxY6dOGGBVI1oQRqJBbC2HOcm45LYg-2ZaljxEfwUv8GXcMOU0iKQJdvyPefch0-WPWX0lFEqX0RKy4LmlFU5Z_N2L1swwXkuOW_uZwvaCJYLXpZH2aMYLyllUpbFw-yoqOqK1kIusu8rSAkCSZ6kNRDobPLhJXGeWGcC6Agd6aENdgTiYJuC34CzmgQbP80ko51B-kYnCy5FEsCA3Vk3kNFuYOjtOAQdk51-fP1mfMBwst4R3xNN4j4mmJBpkLazcEW068gESefa6XEfbZyBAV_9ZL9gJcY7rGAc8ZqC1WMkVzatyUW-fH_-OHvQ4ws8uT6Ps4_nrz8s3-Srdxdvl2er3JRcppw3Rsu6YUUhexCtgIZzwWpZtlWvNe-BtkVXMdaC7BrBWyZ0X-rCtGCqmtWcH2evDrqbbTtBZ7DtoEe1CXbSYa-8tupuxNm1GvxOiZqWktYocHItEPznLcSkJhsNjKN24LdR4SdVFAssK4Q-_wt66bcBZ_MLVXKKdYs_qEGPoKzrPeY1s6g6E0JyxjEvok7_gcLVwWRxsIB_BXcJ7EAwwccYoL_pkVE1-08d_KfQf2r2n5qH8-z2cG4Yvw2HgOIAiBhyA4RbHf1X9SdiR-sZ</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Lehmacher, W.</creator><creator>Klasser, M.</creator><creator>Duering, A.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160501</creationdate><title>Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF</title><author>Lehmacher, W. ; Klasser, M. ; Duering, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cancer patients</topic><topic>Febrile Neutropenia - prevention &amp; control</topic><topic>Female</topic><topic>Filgrastim - therapeutic use</topic><topic>Granulocyte Colony-Stimulating Factor - therapeutic use</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Lymphoma, Non-Hodgkin - drug therapy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neutropenia</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Pain Medicine</topic><topic>Primary Prevention</topic><topic>Rehabilitation Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lehmacher, W.</creatorcontrib><creatorcontrib>Klasser, M.</creatorcontrib><creatorcontrib>Duering, A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database (ProQuest)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lehmacher, W.</au><au>Klasser, M.</au><au>Duering, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>24</volume><issue>5</issue><spage>1935</spage><epage>1937</epage><pages>1935-1937</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><notes>SourceType-Other Sources-1</notes><notes>content type line 63</notes><notes>ObjectType-Correspondence-1</notes><notes>ObjectType-Commentary-2</notes><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26860847</pmid><doi>10.1007/s00520-016-3116-3</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0941-4355
ispartof Supportive care in cancer, 2016-05, Vol.24 (5), p.1935-1937
issn 0941-4355
1433-7339
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4805708
source Social Science Premium Collection; Sociology Collection; Springer Link
subjects Cancer patients
Febrile Neutropenia - prevention & control
Female
Filgrastim - therapeutic use
Granulocyte Colony-Stimulating Factor - therapeutic use
Health aspects
Humans
Letter to the Editor
Lymphoma, Non-Hodgkin - drug therapy
Medicine
Medicine & Public Health
Neutropenia
Nursing
Nursing Research
Oncology
Pain Medicine
Primary Prevention
Rehabilitation Medicine
title Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T20%3A12%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20to%20the%20editor:%20no%20increased%20febrile%20neutropenia%20risk%20to%20cancer%20patients%20receiving%20lipegfilgrastim%E2%80%94correction%20of%20a%20systematic%20review%20and%20meta-analysis%20of%20randomized%20controlled%20trials%20with%20G-CSF&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Lehmacher,%20W.&rft.date=2016-05-01&rft.volume=24&rft.issue=5&rft.spage=1935&rft.epage=1937&rft.pages=1935-1937&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-016-3116-3&rft_dat=%3Cgale_pubme%3EA447313570%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c537t-39ca7891227fe4b4e93341875b6faa3fe0b2d611be7d943b14af5a2cbec681833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1775308754&rft_id=info:pmid/26860847&rft_galeid=A447313570&rfr_iscdi=true